Home | DAIC

investigator Michelle O’Donoghue, MD, MPH, a senior investigator of the TIMI Study Group in the Division of Cardiovascular Medicine. Image courtesy of Michelle O'Donoghue/Brigham and Women's Hospital

FOURIER-OLE Trial Finds that Long-term Use of Evolocumab Further Reduced Cardiovascular Events

September 8, 2022 — A clinical trial led by investigators from Brigham and Women’s Hospital has found that the long-term ...

September 08, 2022

News | Remote Monitoring

Leading Cardiac Remote Monitoring Company Acquires Technology IP to Boost Its Robust Product Portfolio

September 8, 2022 — PrepMD RMS, the premier cardiac clinical solutions company, announced today the acquisition of the ...

September 08, 2022

The OCTARAY Mapping Catheter with TRUEref Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias

News | Catheter

Biosense Webster Launches the OCTARAY Mapping Catheter with TRUErefTechnology

September 8, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech‡, announced the release of the OCTARAY ...

September 08, 2022

Sponsored Content

Feature | Cardiac Imaging

Providing Clarity into CAD

Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...

March 13, 2026

Top 10 content for the month of August 2022

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: A Look at the Hot Topics from August

Here is a rundown of what you and your colleagues found to be most interesting in the fields of diagnostic and ...

September 07, 2022

Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent atrial fibrillation (AF) population

News | Cardiovascular Surgery

Volta Medical’s AI Based solution for Patients in Atrial Fibrillation Achieves Robust Validation in First Peer-Reviewed Publication

September 7, 2022 — Nuwellis, Inc., a commercial-stage company focused on transforming the lives of people with fluid ...

September 07, 2022

Graphical abstract During COVID19 total lockdown in 2020 in France, a significant reduction in vascular stiffness, recorded by home smart scales, was observed.© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society o f Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any me

News | Coronavirus (COVID-19)

Strict COVID Lockdowns in France Improved Cardiovascular Health

September 7, 2022 — A new paper in European Heart Journal - Digital Health, published by Oxford University Press ...

September 07, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

Societies outline recommendations for hardware and software, training, competency, cross-specialty and collaboration

News | SPECT-CT

New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging

September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...

September 07, 2022

Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022

News | Pharmaceuticals

Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

September 6, 2022 — An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and ...

September 06, 2022

Stopping statin treatment early could substantially reduce lifetime protection against heart disease since a large share of the benefit occurs later in life

News | Pharmaceuticals

Study Highlights Lifelong Benefits of Statin Therapy

September 6, 2022 — Stopping statin treatment early could substantially reduce lifetime protection against heart disease ...

September 06, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

Smokers have weaker hearts than non-smokers, according to research

News | Stroke

Smoking is Even More Damaging to the Heart Than Previously Thought

September 6, 2022 — Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 ...

September 06, 2022

Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.

News | Stroke

Air Pollution is Associated with Heart Attacks in Non-Smokers

September 6, 2022 — Research presented at ESC Congress 2022 supports a causal relationship between air pollution and ...

September 06, 2022

BOX trial presented in a Hot Line Session at ESC Congress 2022

News | Sudden Cardiac Arrest

Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

September 2, 2022 — A restrictive oxygenation target in comatose patients resuscitated after out-of-hospital cardiac ...

September 02, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

DELIVER trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Dapagliflozin Benefits Patients with Mildly Reduced and Preserved Ejection Fraction

September 2, 2022 — Dapagliflozin reduces the risk of cardiovascular death or worsening heart failure in heart failure ...

September 02, 2022

ADVOR trial presented in a Hot Line Session at ESC Congress 2022

News | Heart Failure

Acetazolamide Improves Decongestion in Patients with Acute Decompensated Heart Failure

September 2, 2022 — Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients ...

September 02, 2022

DANCAVAS trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Cardiovascular Screening May Reduce Risk of Death and Cardiovascular Disease

September 2, 2022 — A randomized trial in more than 45,000 men has suggested that cardiovascular screening including ...

September 02, 2022